15 September 2025
James Cropper plc
(the "Company")
Director/PDMR Shareholding
The Company has been notified that, on 12 September 2025, David Stirling (Chief Executive Officer) purchased 4,000 ordinary shares of 25p each ("Shares") in the Company. As a result of the transaction, David Stirling holds 13,250 Shares in the Company, representing 0.14% of the Company's issued share capital.
Enquiries:
| James Cropper plc Matt Ratcliffe, General Counsel and Company Secretary |
Tel: +44(0)1539 722002
|
|
|
|
| Shore Capital - Nominated Adviser and Broker Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden
|
Tel: +44 (0)207 408 4090
|
| IFC Advisory - Financial PR Graham Herring, Tim Metcalfe, Zach Cohen
|
Tel: +44 (0) 203 934 6630 |
The following information is included in accordance with Article 19(3) of the Market Abuse Regulation (No. 596/2014):
| 1. |
Details of person discharging managerial responsibilities/person closely associated
|
|||||
| a) |
Name |
David Stirling |
||||
| 2.
|
Reason for the notification |
|||||
| a) |
Position/status |
Chief Executive Officer |
||||
| b) |
Initial notification/amendment |
Initial Notification |
||||
| 3. |
Details of the issuer
|
|||||
| a) |
Name |
James Cropper plc
|
||||
| b) |
Legal Entity Identifier |
213800XM78VTDYGBRM93
|
||||
| 4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.
|
|||||
| a) |
Description of the financial instrument |
Ordinary Shares of 25 pence each |
||||
| b) |
Identification code of the Financial Instrument |
GB0002346053 |
||||
| c) |
Nature of the transaction |
Purchase of ordinary shares. |
||||
| d) |
Currency |
GBP
|
||||
| e) |
Price(s) and volume(s) |
|
||||
| f) |
Aggregated information - volume - Price - Total
|
4,000 £2.70 £10,800 |
||||
| g) |
Date of the transaction |
12 September 2025 |
||||
| h) |
Place of the transaction |
London Stock Exchange |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.